Full Text View
Tabular View
No Study Results Posted
Related Studies
SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
This study has been completed.
Study NCT00005822   Information provided by National Cancer Institute (NCI)
First Received: June 2, 2000   Last Updated: March 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
doxorubicin hydrochloride
semaxanib
conventional surgery
radiation therapy
Additional drug interventions recognized in this trial
Angiogenesis Inhibitors
Doxorubicin
More general drug interventions related to this trial
Angiogenesis Modulating Agents
Antibiotics, Antineoplastic
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Ireland Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services